Ex-Biotech Exec Settles SEC Insider-Trading Case For $148K
A former Trinity Biotech PLC executive has agreed to pay $148,000 to settle allegations he sold his U.S. stock ahead of bad news about the Ireland-based company's effort to sell heart-attack...To view the full article, register now.
Already a subscriber? Click here to view full article